Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Infection01:20

Infection

11.6K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.6K
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

521
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
521
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

674
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
674
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K
Stages of Infection01:26

Stages of Infection

64.7K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
64.7K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

2.6K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.6K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same journal

Current practice patterns among Indian neurologists in the Evaluation and management of Normal Pressure Hydrocephalus: A nationwide cross-sectional survey.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Lecanemab treatment improves B cell subpopulation immune homeostasis in patients with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Modular brain networks shape amyloid-driven tau spread and cognitive decline.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multicenter validation of plasma p-tau217/ amyloid beta 1-42 ratio in symptomatic Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Postmortem brain MRI reveals differential associations of subcortical and limbic volumes with cortical thinning and neurodegenerative pathologies.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Association of sleep duration with Alzheimer's disease and cognition.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jan 7, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
09:07

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

11.5K

Ciencia básica y patogénesis

Sofia Gomes Lopes1

  • 1Polytechnic Institute of Setúbal (IPS), Almada, Setúbal, Portugal.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
Resumen
Este resumen es generado por máquina.

Este estudio presenta una novedosa terapia para la demencia que utiliza células madre pluripotentes inducidas (iPSC) modificadas, combinada con la optimización del microambiente y características de seguridad. El enfoque tiene como objetivo reparar de forma segura el daño cerebral y mejorar la calidad de vida de los pacientes.

Palabras clave:
células madre pluripotentes inducidasterapia de reemplazo celularenfermedades neurodegenerativasreparación de tejido cerebralmodificación del microambientebiosensoresterapia génicainmunomodulacióndemenciamedicina regenerativa

Más Videos Relacionados

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
13:45

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia

Published on: September 21, 2019

6.0K
Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
08:38

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses

Published on: February 22, 2019

6.3K

Videos de Experimentos Relacionados

Last Updated: Jan 7, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
09:07

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

11.5K
A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
13:45

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia

Published on: September 21, 2019

6.0K
Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
08:38

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses

Published on: February 22, 2019

6.3K

Área de la Ciencia:

  • Neurociencia; Medicina Regenerativa; Biotecnología

Sus antecedentes:

  • La demencia presenta un importante desafío de salud global sin cura actual.; Las células madre pluripotentes inducidas (iPSC) muestran potencial para la reparación neuronal, pero enfrentan barreras como el rechazo inmunitario y problemas de integración.; Las limitaciones actuales dificultan la aplicación clínica de las terapias basadas en iPSC para enfermedades neurodegenerativas.

Objetivo del estudio:

  • Desarrollar una estrategia terapéutica segura y eficaz basada en iPSC para la demencia.; Superar los desafíos del rechazo inmunitario y la formación de tumores en el trasplante de iPSC.; Mejorar la integración y la viabilidad a largo plazo de las iPSC mediante la modificación del microambiente y la ingeniería genética.

Principales métodos:

  • Modificación del microambiente cerebral utilizando agentes antiinflamatorios y antioxidantes.; Ingeniería de iPSC con CRISPR-Cas9 para expresar genes supresores de tumores y circuitos apoptóticos.; Integración de biosensores para el monitoreo continuo de la inflamación y las respuestas inmunitarias.

Principales resultados:

  • Las iPSC modificadas alcanzaron una eficiencia de diferenciación del 85% en neuronas funcionales.; Los mecanismos de seguridad redujeron la proliferación celular aberrante en un 90%.; Las intervenciones del microambiente disminuyeron los marcadores inflamatorios en un 40% y mejoraron la viabilidad celular.

Conclusiones:

  • Esta estrategia integrada aborda las barreras clave en la terapia de iPSC para la demencia.; El enfoque muestra promesa para el tratamiento personalizado de enfermedades neurodegenerativas.; Potencial para restaurar la función cognitiva y mejorar la calidad de vida de los pacientes.